Rigel Pharmaceuticals Inc (RIGL) stock
RIGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
$44.46−1.23 (-2.69%)
Close on Nov 13, 2026Market cap $830.51MP/E 2.9Yield –
Rigel Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Rigel Pharmaceuticals's cash was $99.36M at Sep 30, 2026. For fiscal 2025 it was $155.01M, up 100.5% from the year before. Over ten years it grew 2.1% a year on average. The highest annual figure on record is $298.24M in fiscal 2012.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $155.01M | +100.5% |
| FY2024 | Dec 31, 2024 | $77.32M | +35.8% |
| FY2023 | Dec 31, 2023 | $56.93M | -2.2% |
| FY2022 | Dec 31, 2022 | $58.21M | -53.4% |
| FY2021 | Dec 31, 2021 | $124.97M | +118.0% |
| FY2020 | Dec 31, 2020 | $57.33M | -41.5% |
| FY2019 | Dec 31, 2019 | $98.08M | -23.7% |
| FY2018 | Dec 31, 2018 | $128.54M | +11.0% |
| FY2017 | Dec 31, 2017 | $115.75M | +54.8% |
| FY2016 | Dec 31, 2016 | $74.77M | -40.8% |
| FY2015 | Dec 31, 2015 | $126.28M | -11.8% |
| FY2014 | Dec 31, 2014 | $143.16M | -32.5% |
| FY2013 | Dec 31, 2013 | $211.98M | -28.9% |
| FY2012 | Dec 31, 2012 | $298.24M | +20.4% |
| FY2011 | Dec 31, 2011 | $247.64M | +2689.7% |
| FY2010 | Dec 31, 2010 | $8.88M | -39.7% |
| FY2009 | Dec 31, 2009 | $14.72M | -68.0% |
| FY2008 | Dec 31, 2008 | $46.01M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $99.36M | -27.6% |
| Q2 FY2026 | Jun 30, 2026 | $95.39M | -12.0% |
| Q1 FY2026 | Mar 31, 2026 | $146.74M | +90.2% |
| Q4 FY2025 | Dec 31, 2025 | $155.01M | +100.5% |
| Q3 FY2025 | Sep 30, 2025 | $137.20M | +124.5% |
| Q2 FY2025 | Jun 30, 2025 | $108.44M | +120.8% |
| Q1 FY2025 | Mar 31, 2025 | $77.16M | +55.7% |
| Q4 FY2024 | Dec 31, 2024 | $77.32M | +35.8% |
| Q3 FY2024 | Sep 30, 2024 | $61.11M | -2.0% |
| Q2 FY2024 | Jun 30, 2024 | $49.10M | -23.7% |
| Q1 FY2024 | Mar 31, 2024 | $49.55M | -15.5% |
| Q4 FY2023 | Dec 31, 2023 | $56.93M | -2.2% |
| Q3 FY2023 | Sep 30, 2023 | $62.35M | -23.6% |
| Q2 FY2023 | Jun 30, 2023 | $64.36M | -27.8% |
| Q1 FY2023 | Mar 31, 2023 | $58.66M | -45.4% |
| Q4 FY2022 | Dec 31, 2022 | $58.21M | -53.4% |
| Q3 FY2022 | Sep 30, 2022 | $81.64M | -43.0% |
| Q2 FY2022 | Jun 30, 2022 | $89.17M | -41.9% |
| Q1 FY2022 | Mar 31, 2022 | $107.52M | +173.3% |
| Q4 FY2021 | Dec 31, 2021 | $124.97M | +118.0% |
| Q3 FY2021 | Sep 30, 2021 | $143.15M | +96.6% |
| Q2 FY2021 | Jun 30, 2021 | $153.39M | +65.8% |
| Q1 FY2021 | Mar 31, 2021 | $39.35M | -59.0% |
| Q4 FY2020 | Dec 31, 2020 | $57.33M | -41.5% |
| Q3 FY2020 | Sep 30, 2020 | $72.81M | -32.3% |
| Q2 FY2020 | Jun 30, 2020 | $92.50M | -17.7% |
| Q1 FY2020 | Mar 31, 2020 | $95.93M | -25.0% |
| Q4 FY2019 | Dec 31, 2019 | $98.08M | -23.7% |
| Q3 FY2019 | Sep 30, 2019 | $107.48M | -7.1% |
| Q2 FY2019 | Jun 30, 2019 | $112.38M | -16.8% |
| Q1 FY2019 | Mar 31, 2019 | $127.92M | +35.7% |
| Q4 FY2018 | Dec 31, 2018 | $128.54M | +11.0% |
| Q3 FY2018 | Sep 30, 2018 | $115.64M | +69.9% |
| Q2 FY2018 | Jun 30, 2018 | $134.99M | +64.0% |
| Q1 FY2018 | Mar 31, 2018 | $94.30M | -3.9% |
| Q4 FY2017 | Dec 31, 2017 | $115.75M | +54.8% |
| Q3 FY2017 | Sep 30, 2017 | $68.08M | – |
| Q2 FY2017 | Jun 30, 2017 | $82.30M | – |
| Q1 FY2017 | Mar 31, 2017 | $98.14M | – |
| Q4 FY2016 | Dec 31, 2016 | $74.77M | – |
See a number that looks wrong?